Fund moves

Procept Biorobotics (PRCT)Bellevue Group AG reduced its stake -26K shares

Bellevue Group AG reduced its stake in Procept Biorobotics, per its Q3 2025 13F.

463K
Shares reported · -26K vs prior quarter
0.34%
Disclosed portfolio weight
$16.5M
Reported value
Holdings as of
Sep 30, 2025
Filed
Nov 14, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 15, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“Amended Change of Control and Severance Agreements As part of an ongoing evaluation of its executive compensation programs, the Compensation Committee of the Board of Directors of PROCEPT BioRobotics Corporation (the "Company") reviewed the existing form of Change of Control and Severance Agreement for its executive officers below the chief executive officer level and approved certain modifications to better align…”
  2. Nov 4, 2025Company filing · Form 8-K · ResultsReported its results

What came next

  1. Feb 25, 2026Company filing · Form 8-K · ResultsReported its results
  2. Mar 5, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 5, 2026, the board of directors (the “Board”) of PROCEPT BioRobotics Corporation (the “Company”) approved (i) an increase in the size of the Board from eight members to nine members, (ii) appointed Mr. Daniel Puckett as a new member of the Board to fill the resulting vacancy, and (iii) appointed Mr. Puckett as a member of the Audit Committee of the Board, with such appointment effective immediately.”
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Procept Biorobotics

For Procept Biorobotics, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PRCT page.

How this filing works

Other disclosures at Procept Biorobotics

Everything OQRO holds on this company is on its PRCT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data